# Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy

> **NCT01223729** · NA · COMPLETED · sponsor: **University of Catania** · enrollment: 67 (—)

## Conditions studied

- Minimal Hepatic Encephalopathy

## Interventions

- **DRUG:** Acetyl-L-Carnitine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01223729
- **Lead sponsor:** University of Catania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 67 (—)
- **Last updated:** 2010-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01223729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01223729, "Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01223729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*